xi's moments
Home | Americas

Former US health official blames Washington's initial COVID-19 response

Xinhua | Updated: 2021-08-12 10:45

Clinicians depart a patient room after re-positioning a COVID-19 patient into the supine position in the Intensive Care Unit (ICU) at Lake Charles Memorial Hospital on Aug 10, 2021 in Lake Charles, Louisiana. [Photo/Agencies] 

WASHINGTON - A former US federal health official spoke out Wednesday against the former US administration's response to the COVID-19 pandemic, saying thousands of lives could have been saved if Washington acted differently at the outset.

The official claimed he was sacked for opposing former President Donald Trump's push for a certain treatment for COVID-19.

"Hundreds of thousands of lives in the United States and around the world would be saved, people would still be alive today if our government had listened to the science, had been honest and truthful with Americans from the beginning, had told Americans the real risk of this virus and put tools and information and clear messaging out to help people save their lives and protect themselves from getting this virus," said Rick Bright, former director of the Biomedical Advanced Research and Development Authority (BARDA) under the Trump administration.

BARDA is part of the US Department of Health and Human Services (HHS), one of the agencies at the center of the federal government's response to the coronavirus outbreak.

"If we had initiated testing, a really robust nationwide testing strategy to tell people where the virus was and tell people who were infected, if we had done more to prepare for the vaccine administration rollout when the vaccine became available," said Bright, now president of the Rockefeller Foundation.

Bright, a virologist who led BARDA between 2016 and 2020, gave the remarks during an interview with CNN.

Following his removal in April last year, Bright filed a whistleblower complaint purporting that he was ousted because he pressed for rigorous vetting of hydroxychloroquine, an anti-malaria drug embraced by Trump as a coronavirus treatment, and that the administration had put "politics and cronyism ahead of science".

Bright and the HHS had settled the whistleblower complaint, reaching a financial agreement that compensated him for losses including salary, benefits and pension contributions after his abrupt removal, his lawyer said Monday.

The Joe Biden administration also confirmed the settlement, thanking Bright in a statement issued by the HHS "for his dedicated public service and for the contributions he made to addressing the COVID-19 pandemic while he served as BARDA director".

While the HHS under Trump denied any wrongdoing, allegations contained in Bright's whistleblower complaint are now being investigated by the Office of Special Counsel, which protects federal whistleblowers.

Global Edition
BACK TO THE TOP
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349